ARTICLE | Top Story
MOR, SHR antibody deal
December 20, 2001 8:00 AM UTC
Antibody play MorphoSys (NMarkt:MOR) and Schering (SHR; FSE:SCH) signed a 3-year deal to develop 5 antibody therapeutics and multiple in vivo diagnostics. The deal combines MOR's combinatorial antibod...